secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001558370-24-009093
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO stockholders elect three Class I directors, approve say-on-pay and auditor ratification
--------------------------------------------------------------------------------

- Marjan Farid, Andrew Koven, Gregory Perry elected as Class I directors for three-year terms.
- Advisory vote on executive compensation approved with 764,305 votes for, 225,459 against.
- Ratification of Deloitte & Touche LLP as auditor for FY2024 approved (1,825,140 for, 21,748 against).
- Proposal to issue common stock upon conversion of Series E/F/G preferred stock approved (691,010 for, 49,921 against).
- Three proposals to increase beneficial ownership limits on Series E/F/G preferred stock did not pass.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000155837024009093/0001558370-24-009093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000155837024009093/kala-20240611x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer